|Day Low/High||2.68 / 2.83|
|52 Wk Low/High||1.98 / 33.83|
SAN FRANCISCO, April 11, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Indivior PLC (OTC: INVVY) to the firm's investigation of possible Federal securities law violations.
NEW YORK, April 10, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Indivior PLC ("Indivior" or the "Company") (OTCMKTS: INVVY).
Gibbs Law Group is investigating claims on behalf of investors of Indivior PLC (OTC: INVVY) involving possible securities law violations following news that the US Justice Department filed a lawsuit against Indivior for illegal marketing.
U.K. drugmaker balks at Justice Department claims it misled health care providers to push its treatment for opioid addiction.
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Indivior PLC (OTC: INVVY) resulting from allegations that Indivior may have issued materially misleading business...
Company Believes U.S. Justice Department Is Fundamentally Wrong, Will Contest Charges Vigorously
Injecting opioid users may benefit from higher maintenance dose of SUBLOCADE™ (buprenorphine extended-release), a once-monthly injection for the treatment of moderate to severe opioid use disorder
Additional data presented at 50th ASAM Annual Conference supports 18-month safety of SUBLOCADE
Six monthly injections of SUBLOCADE™ improved patient health status and health-related quality of life compared to placebo in 24-week pivotal trial
PERSERIS is the only subcutaneous risperidone-containing long-acting injectable available in the United States
SLOUGH, England and RICHMOND, Va., Feb.
SUBLOCADE - the first FDA-approved monthly injectable buprenorphine treatment for OUD - met primary and key secondary endpoints in the 24-week pivotal trial
RECOVER study designed to understand the long-term clinical, environmental and socio-economic outcomes of SUBLOCADE treated individuals
- Projects full year 2018 revenues over $67 million, exceeding expectations, and projects end-of-year cash and cash equivalents in the range of $58 million to $60 million
Indivior PLC Announces Plan for Commercial Launch in February 2019 with 50 Sales Representatives
SLOUGH, England, Dec. 12, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.
SLOUGH, England, Nov. 27, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that in light of the recent decision by the Court of Appeals for the Federal Circuit (CAFC) vacating the preliminary injunction against...
SUBLOCADE is the first and only once-monthly injectable buprenorphine formulation approved in Canada for the management of moderate to severe opioid use disorder SLOUGH, England and RICHMOND, Va.
-Company will continue to defend its intellectual property and implement contingency plan
PERSERIS delivers risperidone in a new once-monthly extended-release delivery system. Neither a loading dose nor any supplemental oral risperidone is recommended.
SLOUGH, United Kingdom and RICHMOND, Va., Nov.
Act Broadens Access to Medication-Assisted Treatment for People Affected by Opioid Addiction
The U.S. opioid crisis rages on. TheStreet takes a look at several drugs being used to help treat people.
The FTSE 250 pharmaceutical company said the U.S. District Court in Delaware has found that claims of a proposed generic version of Indivior's opioid addiction treatment by Dr. Reddy's does not infringe patents.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.